Annotated abstract

Long-term outcomes for cancer drugs with accelerated approval

dtb · 2025-09-04 · canonical JSON source

5 visible annotations · policy: published · automated confidence ≥ 75.00%

Document resource

Abstract Overview of: Liu ITT, Kesselheim AS, Cliff ERS. Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval. JAMA. 2024;331:1471-9.